PUBLIC CONTRACT · 2022

Medicamentos Antirretrovíricos p/ tratamento de infecção por VIH (SPMS)

Contract value: €445,497.30
Signed on: 1 January 2022
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9185254

PUBLISHED DESCRIPTION

41/57/2022

Parties involved

Contracting body: Centro Hospitalar Universitário do Algarve, E.P.E.
Awardee: GILEAD SCIENCES, LDA.; Abbvie, Lda; JANSSEN CILAG FARMACÊUTICA, LDA.
Place of performance: Portugal
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: GILEAD SCIENCES, LDA. · Tax ID 503604704
Awardee: Abbvie, Lda · Tax ID 510229050
Awardee: JANSSEN CILAG FARMACÊUTICA, LDA. · Tax ID 500189412

Values and timeline

Contract price: €445,497.30
Procedure base price: €0.00
Total effective price: Not reported on Portal BASE
Publication date: 14 April 2022
Award date: 7 October 2021
Signing date: 1 January 2022
Performance period: 90 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Monofator
CPV code: 33690000-3 - Medicamentos vários
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5451893

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts